Belgium· BE-AMP-SAM196122-00

Tetravac

A diphtherie-pertussis-poliomyelitis-tetanus product containing poliovirus type 2 (inactivated), registered in Belgium by Sanofi Winthrop Industrie. The same ATC class is registered in 11 of our 19 countries.

ATC J07CA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTetravacATCJ07CA02REGISTER NO.BE-AMP-SAM196122-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Diphtherie-pertussis-poliomyelitis-tetanus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07CA02 (diphtherie-pertussis-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Diphtherie-pertussis-poliomyelitis-tetanus · ATC J07CA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Poliovirus Type 2 (inactivated)
Manufacturer
Sanofi Winthrop Industrie
Country
Belgium (BE)
ATC code
J07CA02
ATC class
Diphtherie-Pertussis-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2231868

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4ce6b80-84e0-4e7e-b64f-97e0ccbb96db
GET /v1/drugs/c4ce6b80-84e0-4e7e-b64f-97e0ccbb96db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tetravac",
  "name_fr": "Tetravac",
  "name_nl": "Tetravac",
  "amp_code": "SAM196122-00",
  "strengths": [
    "8.0000",
    "8.0000",
    "32.0000",
    "32.0000",
    "25.0000",
    "25.0000",
    "30.0000",
    "30.0000",
    "40.0000",
    "40.0000",
    "25.0000",
    "25.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Poliovirus Type 2 (inactivated)",
    "Poliovirus Type 3 (inactivated)",
    "Pertussis Toxoid Adsorbed (PT)",
    "Diphtheria Toxoid Adsorbed (DT)",
    "Poliovirus Type 1 (inactivated)",
    "Bordetella Pertussis Filamentous Haemagglutinin Adsorbed (FHA)",
    "Tetanus Toxoid Adsorbed",
    "Anhydrous Ethanol",
    "Formaldehyde",
    "Thiomersal - residual product"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Diphtheria-Pertussis-Poliomyelitis-Tetanus",
  "authorisation_numbers": [
    "BE196122"
  ]
}

See everything about diphtherie-pertussis-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.